Structure (Decitabine For Injection 1)
Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 0143-9385
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 0143-9385). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
80964b02 (Decitabine For Injection 2)
Decitabine for Injection is a single-dose sterile cytotoxic agont used for Intravenous Infusion ONLY. Each via of the medicine contains 50mg decitabine, 68mg monobasic potassium phosphate, and 11.6mg sodium hydride. The medicine requires pH adjustment and, package insert and/or carton must be checked for dosage and precautions. Unopened vials should be stored at 20°-25°C (68°F to 77°F) with slight excursions permitted between 15°C to 30°C (S9°F to 86°F). Distributed by Hikima Pharmaceuticals USA Inc., it is manufactured by Jiangsu Hansoh Pharmaceutical Group Co. Ltd., China.*
80965b02 Again (Decitabine For Injection 3)
Decitabine for Injection is a cytotoxic drug meant for intravenous infusion only. It comes in sterile vials containing 50 mg of decitabine, 68 mg monobasic potassium phosphate, and 11.6 mg Sodium hydroxide. The drug must be reconstituted aseptically with sterile water for injection following the package insert. The final concentration should be 5 mg/mL with a pH of 6.7-7.3. Any unused portion of the vial must be discarded. Dilution might be required as per instructions in the package insert. The diluted solution must be used within 15 minutes of preparation if kept at room temperature while refrigeration is needed if stored for a longer period. It must be kept away from children's reach. Consider consulting the package insert for detailed indications, reconstitution, and dosage information before administration.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
